Suppression of fatty acid oxidation supports pancreatic cancer growth and survival under hypoxic conditions through autophagy induction

Cancer Gene Ther. 2023 Jun;30(6):878-889. doi: 10.1038/s41417-023-00598-y. Epub 2023 Feb 17.

Abstract

Hypoxia, one of the key features of solid tumors, induces autophagy, which acts as an important adaptive mechanism for tumor progression under hypoxic environment. Cellular metabolic reprogramming has been correlated with hypoxia, but the molecular connection to the induction of autophagy remains obscure. Here, we show that suppression of fatty acid oxidation (FAO) by hypoxia induces autophagy in human pancreatic ductal adenocarcinoma (PDAC) cells that is required for their growth and survival. Reduced cellular acetyl-CoA levels caused by FAO inhibition decreases LC3 acetylation, resulting in autophagosome formation. Importantly, PDAC cells are significantly dependent on this metabolic reprogramming, as improving FAO leads to a reduction in hypoxia-induced autophagy and an increase in cell death after chemotherapy. Thus, our study supports that suppression of FAO is an important metabolic response to hypoxia and indicates that targeting this pathway in PDAC may be an effective therapeutic approach.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy
  • Carcinoma, Pancreatic Ductal* / genetics
  • Carcinoma, Pancreatic Ductal* / therapy
  • Cell Line, Tumor
  • Cell Proliferation / physiology
  • Fatty Acids / pharmacology
  • Fatty Acids / therapeutic use
  • Humans
  • Hypoxia
  • Pancreatic Neoplasms* / drug therapy
  • Pancreatic Neoplasms* / therapy

Substances

  • Fatty Acids